News U.S. Stem Cell, Inc.

Equities

USRM

US90350U1007

Delayed OTC Markets Other stock markets 01:12:59 03/05/2024 am IST			5-day change	1st Jan Change
0.000001 ^USD	-99.00%		0.00%	0.00%

2023	U.S. Stem Cell, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
2023	U.S. Stem Cell, Inc. Auditor Raises 'Going Concern' Doubt	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

U.S. STEM CELL, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	15/23/15	AQ
U.S. Stem Cell, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	15/23/15	CI
U.S. Stem Cell, Inc. Auditor Raises 'Going Concern' Doubt	14/23/14	CI
NOTE 2 - GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS	10/22/10	AQ
U.S. Stem Cell, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	10/22/10	CI
U.S. STEM CELL, INC. - 10-K/A - Management's Discussion and Analysis of Financial Condition and Results of Operations	09/22/09	AQ
NOTE 2 - GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS	24/22/24	AQ
U.S. Stem Cell, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	24/22/24	CI
U.S. Stem Cell, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	01/22/01	CI
U.S. STEM CELL, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	01/22/01	AQ
U.S. Stem Cell, Inc. Auditor Raises 'Going Concern' Doubt	31/22/31	CI
U S Stem Cell : Material Event - Form 8-K/A	10/22/10	PU
U.S. STEM CELL, INC. Other Events (form 8-K/A)	10/22/10	AQ
U S Stem Cell : Mark Borman appointed Chairman of the Board of USRM	09/22/09	PU
U.S. STEM CELL, INC. : Other Events (form 8-K)	09/22/09	AQ
U.S. Stem Cell, Inc. Announces Management Changes	09/22/09	CI
NOTE 2 - GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS	10/21/10	AQ
U.S. Stem Cell, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	10/21/10	CI
U S Stem Cell : USRM to Focus on Animal Health and Lead Pet-Care Innovation	19/21/19	PU
U S Stem Cell : NOTE 2 - GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS	13/21/13	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News U.S. Stem Cell, Inc.

Equities

USRM

US90350U1007

Summary

Filters